Groin soft tissue tumors?a challenge for local control and reconstruction: A prospective cohort analysis

2004 ◽  
Vol 86 (3) ◽  
pp. 147-151 ◽  
Author(s):  
L.A. Mack ◽  
Walley J. Temple ◽  
W.G. DeHaas ◽  
N. Schachar ◽  
D.G. Morris ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Local Control ◽  
Prospective Cohort ◽  
Cohort Analysis ◽  
Soft Tissue Tumors

Prophylactic lymphaticovenous anastomoses for resection of soft tissue tumors of the thigh to prevent secondary lymphedema–a retrospective comparative cohort analysis

Microsurgery ◽  
2021 ◽  
Author(s):  
Johannes Maximilian Wagner ◽  
Mehran Dadras ◽  
Dominic Ufton ◽  
Julika Huber ◽  
Christoph Wallner ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Cohort Analysis ◽  
Soft Tissue Tumors ◽  
Secondary Lymphedema

03:36 PM Abstract No. 57 Are preprocedural labs for extremity bone and soft tissue biopsies necessary? A prospective cohort analysis

2019 ◽  
Vol 30 (3) ◽  
pp. S28
Author(s):  
S. Mehta ◽  
R. Sebro ◽  
S. Trerotola ◽  
M. Nawas ◽  
K. Weber ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Prospective Cohort ◽  
Cohort Analysis

Localization of Gallium-67 in Peritoneal Cells by Electron Microscopic Autoradiography

1973 ◽  
Vol 31 ◽  
pp. 404-405
Author(s):  
D. C. Swartzendruber ◽  
Norma L. Idoyaga-Vargas
Keyword(s):  
Clinical Trials ◽  
Soft Tissue ◽  
Tumor Tissue ◽  
Soft Tissue Tumors ◽  
Clinical Usefulness ◽  
Electron Microscopic ◽  
Normal Cells ◽  
Electron Microscopic Autoradiography ◽  
Peritoneal Cells ◽  
Gallium 67

The radionuclide gallium-67 (67Ga) localizes preferentially but not specifically in many human and experimental soft-tissue tumors. Because of this localization, 67Ga is used in clinical trials to detect humar. cancers by external scintiscanning methods. However, the fact that 67Ga does not localize specifically in tumors requires for its eventual clinical usefulness a fuller understanding of the mechanisms that control its deposition in both malignant and normal cells. We have previously reported that 67Ga localizes in lysosomal-like bodies, notably, although not exclusively, in macrophages of the spocytaneous AKR thymoma. Further studies on the uptake of 67Ga by macrophages are needed to determine whether there are factors related to malignancy that might alter the localization of 67Ga in these cells and thus provide clues to discovering the mechanism of 67Ga localization in tumor tissue.

Benign Skin and Soft-Tissue Tumors of the Hand

1987 ◽  
Vol 14 (2) ◽  
pp. 403-412
Author(s):  
Saleh M. Shenaq
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Tumors ◽  
Tumors Of The Hand

Percutaneous Imaging-Guided versus Open Musculoskeletal Biopsy: Concepts and Controversies

2020 ◽  
Vol 24 (06) ◽  
pp. 667-675
Author(s):  
Violeta Vasilevska Nikodinovska ◽  
Slavcho Ivanoski ◽  
Milan Samardziski ◽  
Vesna Janevska
Keyword(s):  
Soft Tissue ◽  
Complication Rate ◽  
Core Needle Biopsy ◽  
Multidisciplinary Team ◽  
Gold Standard ◽  
Needle Biopsy ◽  
Soft Tissue Tumors ◽  
Open Biopsy ◽  
Core Needle ◽  
Similar Accuracy

AbstractBone and soft tissue tumors are a largely heterogeneous group of tumors. Biopsy of musculoskeletal (MSK) tumors is sometimes a challenging procedure. Although the open biopsy is still considered the gold standard for the biopsy of MSK lesions, core needle biopsy can replace it in most cases, with similar accuracy and a low complication rate. The biopsy should be performed in a tertiary sarcoma center where the multidisciplinary team consists of at minimum a tumor surgeon, an MSK pathologist, and an MSK radiologist who can assess all steps of the procedure. Several factors can influence the success of the biopsy including the lesion characteristics, the equipment, and the method used for the procedure. This review highlights some of the important aspects regarding the biopsy of the MSK tumors, with special attention to imaging a guided core needle biopsy and highlighting some of the recent advancements and controversies in the field.

Evaluation of Lipomatous Soft Tissue Tumors by MR Imaging

1994 ◽  
Vol 35 (4) ◽  
pp. 367-370 ◽  
Author(s):  
J. Gelineck ◽  
J. Keller ◽  
O. Myhre Jensen ◽  
O. Steen Nielsen ◽  
T. Christensen
Keyword(s):  
Soft Tissue ◽  
Mr Imaging ◽  
Soft Tissue Tumors

Diagnostic Imaging of Fetal and Neonatal Abdominal and Soft Tissue Tumors

2015 ◽  
Vol 11 (3) ◽  
pp. 143-150 ◽  
Author(s):  
Usha D. Nagaraj ◽  
Beth M. Kline-Fath
Keyword(s):  
Soft Tissue ◽  
Diagnostic Imaging ◽  
Soft Tissue Tumors

Imaging of soft tissue tumors

2020 ◽  
Vol 16 ◽  
Author(s):  
Shinji Tsukamoto ◽  
Andreas F. Mavrogenis ◽  
Yasuhito Tanaka ◽  
Costantino Errani
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Soft Tissue ◽  
Tumor Size ◽  
Critical Role ◽  
Evaluation Criteria ◽  
Soft Tissue Tumors ◽  
Resonance Imaging ◽  
Benign Soft Tissue Tumors ◽  
Response To Chemotherapy

: Differentiation of malignant from benign soft tissue tumors is challenging with imaging alone, including that by magnetic resonance imaging and computed tomography. However, the accuracy of this differentiation has increased owing to the development of novel imaging technology. Detailed patient history and physical examination remain essential for differentiation between benign and malignant soft tissue tumors. Moreover, measurement only of tumor size based on Response Evaluation Criteria In Solid Tumors criteria is insufficient for the evaluation of response to chemotherapy or radiotherapy. Change in metabolic activity measured by 18F-fluorodeoxyglucose positron emission tomography or dynamic contrast enhanced-derived quantitative endpoints can more accurately evaluate treatment response compared to change in tumor size. Magnetic resonance imaging can accurately evaluate essential factors in surgical planning such as vascular or bone invasion and “tail sign”. Thus, imaging plays a critical role in the diagnosis and treatment of soft tissue tumors.

Sign in / Sign up

Export Citation Format

Share Document